| 000 | 01860 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515211911.0 | ||
| 264 | 0 | _c20100709 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2010-01-263533 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeers, Stephen A | |
| 245 | 0 | 0 |
_aAntigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection. _h[electronic resource] |
| 260 |
_bBlood _cJun 2010 |
||
| 300 |
_a5191-201 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntigen-Antibody Complex _ximmunology |
| 650 | 0 | 4 |
_aAntigens, CD20 _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _ximmunology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aMacrophages _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aReceptors, IgG _ximmunology |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aFrench, Ruth R | |
| 700 | 1 | _aChan, H T Claude | |
| 700 | 1 | _aLim, Sean H | |
| 700 | 1 | _aJarrett, Timothy C | |
| 700 | 1 | _aVidal, Regina Mora | |
| 700 | 1 | _aWijayaweera, Sahan S | |
| 700 | 1 | _aDixon, Sandra V | |
| 700 | 1 | _aKim, Hyungjin | |
| 700 | 1 | _aCox, Kerry L | |
| 700 | 1 | _aKerr, Jonathan P | |
| 700 | 1 | _aJohnston, David A | |
| 700 | 1 | _aJohnson, Peter W M | |
| 700 | 1 | _aVerbeek, J Sjef | |
| 700 | 1 | _aGlennie, Martin J | |
| 700 | 1 | _aCragg, Mark S | |
| 773 | 0 |
_tBlood _gvol. 115 _gno. 25 _gp. 5191-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2010-01-263533 _zAvailable from publisher's website |
| 999 |
_c19590228 _d19590228 |
||